Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 8, 2020Diabetes Obesity and Metabolism

Sodium‐glucose co‐transporter‐2 inhibitors and the risk of urosepsis: A multi‐site, prevalent new‐user cohort study

View Full Paper
Ask AI
Bookmark
Share

Authors

AFAnat FisherMFMichael FralickKFKristian B. Filion

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Fisher et al. (2020) studied this question.

synapsesocial.com/papers/6a7cb5df7c7b1859d4ba4e8fhttps://doi.org/10.1111/dom.14082
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Data Resource Profile: Clinical Practice Research Datalink (CPRD)2015 · 2,781 citations
  2. 2Use of sodium-glucose cotransporter-2 inhibitors and urinary tract infections in type 2 diabetes patients: a systematic review2019 · 27 citations
  3. 3The Intention-to-Treat Principle2014 · 641 citations
  4. 4A Systematic Review and Meta-Analysis of Randomized Trials2007 · 113 citations
  5. 5Sodium glucose cotransporter 2 inhibitors and risk of genital mycotic and urinary tract infection: A population‐based study of older women and men with diabetes2019 · 167 citations